Forsythin inhibits lipopolysaccharide-induced inflammation by suppressing JAK-STAT and p38 MAPK signalings and ROS production
暂无分享,去创建一个
[1] L. Luo,et al. Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production , 2013, Inflammation Research.
[2] Jiyun Song,et al. Inducible HSP70 Antagonizes IL-1β Cytocidal Effects through Inhibiting NF-kB Activation via Destabilizing TAK1 in HeLa Cells , 2012, PloS one.
[3] Yongming Zhang,et al. Isoforsythiaside, an antioxidant and antibacterial phenylethanoid glycoside isolated from Forsythia suspensa. , 2012, Bioorganic chemistry.
[4] 坂口 正展. Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells , 2012 .
[5] Li Qinghua,et al. Study on the content of forsythin, total flavonoids of Forsythia suspensa and their antioxidant activity. , 2012 .
[6] L. Luo,et al. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. , 2012, International immunopharmacology.
[7] M. Parnham,et al. Journal status and new developments , 2012, Inflammation Research.
[8] Jin-Shui Pan,et al. Reactive oxygen species: A double-edged sword in oncogenesis , 2009 .
[9] J. Kang,et al. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling. , 2008, The Journal of nutrition.
[10] Yumei Fan,et al. Dipyrithione inhibits lipopolysaccharide‐induced iNOS and COX‐2 up‐regulation in macrophages and protects against endotoxic shock in mice , 2008, FEBS letters.
[11] Yan Wang,et al. Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa , 2008, The Journal of pharmacy and pharmacology.
[12] P. Murray. The JAK-STAT Signaling Pathway: Input and Output Integration1 , 2007, The Journal of Immunology.
[13] M. Vitiello,et al. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6. , 2006, Cytokine.
[14] O. Aruoma,et al. Free radicals in biology and medicine: from inflammation to biotechnology. , 2006, BioFactors.
[15] A. Hoffmann,et al. Circuitry of nuclear factor kappaB signaling. , 2006, Immunological reviews.
[16] C. Tsatsanis,et al. Signalling networks regulating cyclooxygenase-2. , 2006, The international journal of biochemistry & cell biology.
[17] Feng Chen,et al. Preparative isolation and purification of phillyrin from the medicinal plant Forsythia suspensa by high-speed counter-current chromatography. , 2005, Journal of chromatography. A.
[18] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[19] C. Litterst,et al. The role of STATs in inflammation and inflammatory diseases. , 2004, Current pharmaceutical design.
[20] K. Shuai,et al. Regulation of JAK–STAT signalling in the immune system , 2003, Nature Reviews Immunology.
[21] S. Okugawa,et al. Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. , 2003, American journal of physiology. Cell physiology.
[22] Soo Young Park,et al. 15d-PGJ2 and Rosiglitazone Suppress Janus Kinase-STAT Inflammatory Signaling through Induction of Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 in Glia* , 2003, The Journal of Biological Chemistry.
[23] H. Liou,et al. Regulation of the Immune System by NF-κB and IκB , 2002 .
[24] T. Lawrence,et al. Anti-inflammatory lipid mediators and insights into the resolution of inflammation , 2002, Nature Reviews Immunology.
[25] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[26] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[27] S. Bhattacharya,et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.
[28] J. Ríos,et al. Antioxidant activity of anti-inflammatory plant extracts. , 2002, Life sciences.
[29] R. DuBois,et al. Cyclooxygenase-2: a therapeutic target. , 2002, Annual review of medicine.
[30] H. Liou,et al. Regulation of the immune system by NF-kappaB and IkappaB. , 2002, Journal of biochemistry and molecular biology.
[31] Y. Ohmori,et al. Requirement for STAT1 in LPS‐induced gene expression in macrophages , 2001, Journal of leukocyte biology.
[32] E. Chan,et al. IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line , 2001 .
[33] D. Levy,et al. Specificity of signaling by STAT1 depends on SH2 and C‐terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression , 2001, The EMBO journal.
[34] M. Wasko,et al. Inflammation-mediated rheumatic diseases and atherosclerosis. , 2000, Annals of the rheumatic diseases.
[35] Michael Karin,et al. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .
[36] C. C. Chen,et al. Antioxidant Principles from Ephemerantha lonchophylla. , 2000, Journal of natural products.
[37] M. Karin,et al. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. , 2000, Seminars in immunology.
[38] P. Cohen,et al. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[39] Y. Kuo,et al. Antioxidant principles from Ephemerantha lonchophylla. , 1999, Journal of natural products.
[40] Lin,et al. Involvement of p38 mitogen‐activated protein kinase in lipopolysaccharide‐induced iNOS and COX‐2 expression in J774 macrophages , 1999, Immunology.
[41] S. Moncada. Nitric oxide: discovery and impact on clinical medicine , 1999, Journal of the Royal Society of Medicine.
[42] G. Hunninghake,et al. Both Erk and p38 kinases are necessary for cytokine gene transcription. , 1999, American journal of respiratory cell and molecular biology.
[43] N. Aikawa,et al. The natural history of the systemic inflammatory response syndrome and the evaluation of SIRS criteria as a predictor of severity in patients hospitalized through emergency services. , 1999, The Keio journal of medicine.
[44] B. Cochran,et al. Activation of the JAK-STAT pathway by reactive oxygen species. , 1998, American journal of physiology. Cell physiology.
[45] G. Laurent,et al. Pulmonary fibrosis: cytokines in the balance. , 1998, The European respiratory journal.
[46] M. Recio,et al. Screening of antiinflammatory medicinal plants used in traditional medicine against skin diseases , 1998 .
[47] W. Buurman,et al. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model. , 1998, Cytokine.
[48] M. Satake,et al. Antiinflammatory effect of Forsythia suspensa Vahl and its active fraction. , 1997, Biological & pharmaceutical bulletin.
[49] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[50] John C. Lee,et al. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms , 1996, Journal of leukocyte biology.
[51] D. Baltimore,et al. NF-kappa B: ten years after. , 1996, Cell.
[52] J. Darnell,et al. Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.
[53] D. Pittet,et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.
[54] T. Kirikae,et al. Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.